Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585597 · ClinicalTrials.gov registry record · Phase 1
Reperfusion With Cooling in Cerebral Acute Ischemia
A Phase 1 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01585597 is a Phase 1 study that has completed, run by Emory University. The registered enrollment target is 20 participants.
The verdict
NCT01585597, a Phase 1 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether reducing a patients body temperature (mild hypothermia of 33 degrees Centigrade) will significantly reduce the risk of brain injury (notably reperfusion injury and hemorrhagic conversion) in patients that have suffered a significant interruption of blood flow to an area of brain (occlusion of large proximal cerebral artery) and have undergone successful removal of that interruption (revascularization).
Interventions
- DEVICE Zoll- Coolgaurd 3000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01585597
The ClinicalTrials.gov registry entry for NCT01585597 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zoll- Coolgaurd 3000 is the first listed.
NCT01585597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01585597 about?
NCT01585597 is a clinical study titled "Reperfusion With Cooling in Cerebral Acute Ischemia". The purpose of this study is to determine whether reducing a patients body temperature (mild hypothermia of 33 degrees Centigrade) will significantly reduce the risk of brain injury (notably reperfusion injury and hemorrhagic conversion) in patients that have suffered a significant interruption of b...
What is the current status of trial NCT01585597?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01585597?
The interventions under investigation include: Zoll- Coolgaurd 3000 (DEVICE).
Who is sponsoring clinical trial NCT01585597?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.